Obparp-100 Tablet 8's Substitute
Sun Pharmaceutical Industries Ltd
₹294.5
(₹4.91 per unit)
Intas Pharmaceuticals Ltd
₹4200
(₹140.0 per unit)
Adley Formulations
₹9000
(₹150.0 per unit)
Dr Reddy's Laboratories Ltd
₹10000
(₹166.67 per unit)
Hetero Healthcare Pvt Ltd
₹6100
(₹203.33 per unit)
Natco Pharma Ltd
₹6459
(₹215.3 per unit)
Zydus Healthcare Ltd
₹13120
(₹218.67 per unit)
Eris Life Sciences Ltd
₹15500
(₹258.33 per unit)
Lupin Ltd
₹17500
(₹291.67 per unit)
Samarth Life Sciences Pvt Ltd
₹14062.5
(₹468.75 per unit)
Emcure Pharmaceuticals Ltd
₹36000
(₹600.0 per unit)
Maximal Healthcare Pvt Ltd
₹40500
(₹675.0 per unit)
BDR Pharmaceuticals Internationals Pvt Ltd
₹18984
(₹678.0 per unit)
BDR Pharmaceuticals Internationals Pvt Ltd
₹40500
(₹723.21 per unit)
Steris Healthcare
₹40620
(₹5077.5 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Obparp-100 Tablet 8's to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - OLAPARIB-100MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Obparp-100 Tablet 8's is used in the treatment of Ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. The detailed uses of Obparp-100 Tablet 8's are as follows:
Obparp-100 Tablet 8's belongs to a group of medicines known as 'anti-cancer' drugs used to treat various cancers, including Ovarian, breast, pancreatic, and prostate. Obparp-100 Tablet 8's contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
RX